Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leongamornlert

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersE Castro, S Jugurnauth-Little, Q Karlsson, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Human Genetics|April 6, 2011
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcriptZ Kote-Jarai, A Amin Al Olama, D Leongamornlert, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersE Castro, S Jugurnauth-Little, Q Karlsson, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Human Genetics|April 6, 2011
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcriptZ Kote-Jarai, A Amin Al Olama, D Leongamornlert, et al.
Pageof 1